EVASAYIL Trademark

Trademark Overview


On Thursday, March 2, 2023, a trademark application was filed for EVASAYIL with the United States Patent and Trademark Office. The USPTO has given the EVASAYIL trademark a serial number of 79366952. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The EVASAYIL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of immunology, oncology, immuno-oncology and autosomal-recessive disorder; providing medical and scientific research information in the field of immunology, oncology, immuno-oncology and autosomal-recessive disorder
evasayil

General Information


Serial Number79366952
Word MarkEVASAYIL
Filing DateThursday, March 2, 2023
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7416464
Registration DateTuesday, June 18, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and ServicesMedical and scientific research in the field of immunology, oncology, immuno-oncology and autosomal-recessive disorder; providing medical and scientific research information in the field of immunology, oncology, immuno-oncology and autosomal-recessive disorder

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Friday, April 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 14, 2023APPLICATION FILING RECEIPT MAILED
Thursday, August 31, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023NON-FINAL ACTION WRITTEN
Saturday, September 2, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 21, 2023REFUSAL PROCESSED BY MPU
Thursday, September 21, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 11, 2023REFUSAL PROCESSED BY IB
Monday, January 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 27, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 16, 2024NOTIFICATION PROCESSED BY IB
Thursday, February 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER